180 related articles for article (PubMed ID: 25819277)
1. Hybrid protein-synthetic polymer nanoparticles for drug delivery.
Koseva NS; Rydz J; Stoyanova EV; Mitova VA
Adv Protein Chem Struct Biol; 2015; 98():93-119. PubMed ID: 25819277
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
3. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
4. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
6. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
7. Drug Delivery Nanocarriers from a Fully Degradable PEG-Conjugated Polyester with a Reduction-Responsive Backbone.
Yameen B; Vilos C; Choi WI; Whyte A; Huang J; Pollit L; Farokhzad OC
Chemistry; 2015 Aug; 21(32):11325-9. PubMed ID: 26177931
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
9. Thiol-responsive gemini poly(ethylene glycol)-poly(lactide) with a cystine disulfide spacer as an intracellular drug delivery nanocarrier.
Kim HC; Kim E; Ha TL; Jeong SW; Lee SG; Lee SJ; Lee B
Colloids Surf B Biointerfaces; 2015 Mar; 127():206-12. PubMed ID: 25679493
[TBL] [Abstract][Full Text] [Related]
10. Amorphous calcium silicate hydrate/block copolymer hybrid nanoparticles: synthesis and application as drug carriers.
Wu J; Zhu YJ; Chen F; Zhao XY; Zhao J; Qi C
Dalton Trans; 2013 May; 42(19):7032-40. PubMed ID: 23511873
[TBL] [Abstract][Full Text] [Related]
11. Hybrid polymeric micelles based on bioactive polypeptides as pH-responsive delivery systems against melanoma.
Wang QM; Gao Z; Liu S; Fan B; Kang L; Huang W; Jin M
Biomaterials; 2014 Aug; 35(25):7008-21. PubMed ID: 24875757
[TBL] [Abstract][Full Text] [Related]
12. Polypeptide-based "smart" micelles for dual-drug delivery: a combination study of experiments and simulations.
Chen L; Jiang T; Cai C; Wang L; Lin J; Cao X
Adv Healthc Mater; 2014 Sep; 3(9):1508-17. PubMed ID: 24652770
[TBL] [Abstract][Full Text] [Related]
13. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
[TBL] [Abstract][Full Text] [Related]
14. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporally programmable surface engineered nanoparticles for effective anticancer drug delivery.
Ahmed A; Yu H; Han D; Rao J; Ding Y; Hu Y
Macromol Biosci; 2014 Nov; 14(11):1652-62. PubMed ID: 25181029
[TBL] [Abstract][Full Text] [Related]
16. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
17. Micellar nanoparticle formation via electrostatic interactions for delivering multinuclear platinum(II) drugs.
Xiao H; Stefanick JF; Jia X; Jing X; Kiziltepe T; Zhang Y; Bilgicer B
Chem Commun (Camb); 2013 May; 49(42):4809-11. PubMed ID: 23595166
[TBL] [Abstract][Full Text] [Related]
18. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents.
Bae Y; Diezi TA; Zhao A; Kwon GS
J Control Release; 2007 Oct; 122(3):324-30. PubMed ID: 17669540
[TBL] [Abstract][Full Text] [Related]
19. Drug delivery's quest for polymers: Where are the frontiers?
Merkle HP
Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):293-303. PubMed ID: 26614554
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
